These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10192145)

  • 1. Anticoagulation with prostaglandins during extracorporeal circulation.
    Kozek-Langenecker SA
    Wien Klin Wochenschr; 1999 Feb; 111(4):129-40. PubMed ID: 10192145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
    J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect--anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin.
    von Heymann C; Hagemeyer E; Kastrup M; Ziemer S; Proquitté H; Konertz WF; Spies C
    Pediatr Crit Care Med; 2006 Jul; 7(4):383-5. PubMed ID: 16738494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
    Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
    Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist.
    Bein T; Zimmermann M; Philipp A; Ramming M; Sinner B; Schmid C; Müller T; Graf B; Schlitt HJ; Weber-Carstens S
    ASAIO J; 2011; 57(3):164-8. PubMed ID: 21427564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre- and intraoperative management of heparin cross hypersensitivity. Apropos of a case].
    Latrémouille C; Massonnet-Castel S; Baron JF; Renaudin JM; Cardon C; Fabiani JN; Carpentier A
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1305-9. PubMed ID: 8952830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Selleng S; Greinacher A
    Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: use of heparin and epoprostenol combined with on-line monitoring of platelet function.
    Mertzlufft F; Kuppe H; Koster A
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):304-8. PubMed ID: 10890486
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant and antiplatelet therapy for cardiac surgery].
    Okuyama H; Hashimoto K
    Kyobu Geka; 2008 Jul; 61(8 Suppl):667-73. PubMed ID: 20715407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulant therapy and cardiopulmonary bypass].
    Lespron Robles Mdel C; Molina Méndez J
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.